ADC Therapeutics' Private Equity - II Round

ADC Therapeutics raised a round of funding on October 16, 2013. Investors include Auven Therapeutics.

ADC Therapeutics (ADCT) is an oncology drug development company that specializes in the development of proprietary Antibody Drug Conjugates (ADCs) targeting major solid and hematological cancers. The …

Articles about ADC Therapeutics' Private Equity - II Round: